Dalbavancin treatment of methicillin-susceptible Staphylococcus aureus pyomyositis with torpid evolution: a case report. | Rev Esp Quimioter;32(3): 276-277, 2019 Jun. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Dalbavancin treatment of methicillin-susceptible Staphylococcus aureus pyomyositis with torpid evolution: a case report.

Álvarez Otero, J; Sanjurjo Rivo, A; Lamas Ferreiro, J L; de la Fuente Aguado, J.

Affiliation

Álvarez Otero J; Judith Álvarez Otero, C/Tarragona, 2, 4º A. CP: 36211. Vigo (Pontevedra). Spain. judithao@hotmail.com.

Rev Esp Quimioter ; 32(3): 276-277, 2019 Jun.

Article in En | MEDLINE | ID: mdl-31037932

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Staphylococcal Infections / Staphylococcus aureus / Teicoplanin / Pyomyositis / Anti-Bacterial Agents Limits: Humans / Male / Middle aged Language: En Journal: Rev Esp Quimioter Journal subject: TERAPIA POR MEDICAMENTOS Year: 2019 Document type: Article Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Staphylococcal Infections / Staphylococcus aureus / Teicoplanin / Pyomyositis / Anti-Bacterial Agents Limits: Humans / Male / Middle aged Language: En Journal: Rev Esp Quimioter Journal subject: TERAPIA POR MEDICAMENTOS Year: 2019 Document type: Article Country of publication: